Hospital-Acquired Acute Kidney Injury in Noncritical Care Setting: Clinical Characteristics and Outcomes
Table 4
Clinical outcomes of patients with hospital-acquired AKI based on nephrology consultation.
All patients
Nephrology consultation (n = 31)
No nephrology consultation (n = 191)
Recovery
Complete (N (%))
144 (64.9)
16 (51.6)
128 (67)
0.022
Partial (N (%))
34 (15.3)
4 (12.9)
30 (15.7)
No (N (%))
44 (19.8)
11(35.5)
33 (17.3)
Discharge SCr, μmol/L (mean (SD))
130.5 (82)
218.3 (153.1)
116.3 (51.5)
Median (IQR)
106.5 (83.8–145.5)
152 (101–337)
101 (82–134)
<0.001
Length of hospitalisation, days (mean (SD))
10.3 (8)
14.9 (10.7)
9.5 (7.4)
Median (IQR)
8 (5–13)
13 (6–19)
7 (5–12)
0.003
In-hospital mortality (N (%))
24 (10.8)
4 (12.9)
20 (10.5)
0.754
Time of AKI to hospital discharge (mean (SD)) days
7.8 (7.7)
12.4 (10.2)
7.0 (7)
Median (IQR)
5.5 (3–11)
10 (4–18)
5 (3–9)
0.001
KDIGO stage at time of recovery/discharge (N (%))
Stage 1
65 (29.3)
5 (16.1)
60 (31.4)
Stage 2
6 (2.7)
5 (16.1)
1 (0.5)
Stage 3
7 (3.2)
5 (16.1)
2 (0.9)
Categorical variables are compared using Chi-square tests or Fisher-Exact test (depending on counts within individual categorisation); means of two groups are compared using the t-test; continuous variables are compared using the Mann–Whitney U test.
